期刊
CANCER IMMUNOLOGY IMMUNOTHERAPY
卷 58, 期 11, 页码 1771-1780出版社
SPRINGER
DOI: 10.1007/s00262-009-0685-8
关键词
Complement system; Hypoxia; Lung cancer
资金
- Cancer-fonden
- Swedish Foundation for Strategic Research (INGVAR)
- Swedish Medical Research Council
- Foundations of Osterlund
- Kock
- King Gustav V's 80th Anniversary Foundation
- Knut and Alice Wallenberg Foundation
- Inga-Britt and Arne Lundberg Foundation
- University Hospital in Malmo
- UTE Project CIMA
- RTICC
- Spanish Ministry of Education and Science [SAF-2005-01302]
The complement system can be specifically targeted to tumor cells due to molecular changes on their surfaces that are recognized by complement directly or via naturally occurring antibodies. However, tumor cells often overexpress membrane-bound complement inhibitors protecting them from complement attack. We have previously shown that non-small cell lung cancer (NSCLC) cells, additionally to membrane-bound inhibitors, produce substantial amounts of soluble regulators such as factor I (FI) and factor H (FH). Since low oxygen concentration is associated with rapidly growing solid tumors, we studied how NSCLC cells protect themselves from complement attack under hypoxic conditions. Unexpectedly, mRNA levels and secretion of both FI and FH were significantly decreased already after 24 h exposure to hypoxia while cell viability measured by XTT assay and annexin V/7-AAD staining was affected only marginally. Furthermore, we observed decrease of mRNA level and loss of membrane-bound complement inhibitor CD46 and increased deposition of early (C3b) and terminal (C9) complement components on hypoxic NSCLC cells. All three complement pathways (classical, lectin and alternative) were employed to deposit C3b on cell surface. Taken together, our results imply that under hypoxic conditions NSCLC give up some of their available defense mechanisms and become more prone to complement attack.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据